131 related articles for article (PubMed ID: 30317675)
21. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.
Jędroszka D; Orzechowska M; Hamouz R; Górniak K; Bednarek AK
PLoS One; 2017; 12(12):e0188842. PubMed ID: 29206234
[TBL] [Abstract][Full Text] [Related]
22.
Zhou J; Yang X; Song P; Wang H; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305
[No Abstract] [Full Text] [Related]
23. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
Yang Y; Sun P; Xu W; Xia W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809694. PubMed ID: 30376767
[TBL] [Abstract][Full Text] [Related]
24. HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
Komatsu H; Iguchi T; Masuda T; Ueda M; Kidogami S; Ogawa Y; Nambara S; Sato K; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Anticancer Res; 2016 Jun; 36(6):2767-73. PubMed ID: 27272787
[TBL] [Abstract][Full Text] [Related]
25. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
[TBL] [Abstract][Full Text] [Related]
26. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
Zhang L; Guo F; Gao X; Wu Y
Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics.
Cai JQ; Xu XW; Mou YP; Chen K; Pan Y; Wu D
Tumour Biol; 2016 Feb; 37(2):1641-50. PubMed ID: 26307396
[TBL] [Abstract][Full Text] [Related]
29. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of HOXB7 promotes proliferation and metastasis of osteosarcoma cells.
Yang Y; Chen J; Chen Q
Mol Med Rep; 2017 Sep; 16(3):2773-2778. PubMed ID: 28677742
[TBL] [Abstract][Full Text] [Related]
31. Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.
Mo RJ; Lu JM; Wan YP; Hua W; Liang YX; Zhuo YJ; Kuang QW; Liu YL; He HC; Zhong WD
Curr Mol Med; 2017; 17(1):70-78. PubMed ID: 28231752
[TBL] [Abstract][Full Text] [Related]
32. Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.
Li H; Shen LY; Yan WP; Dong B; Kang XZ; Dai L; Yang YB; Fu H; Yang HL; Zhou HT; Huang C; Liang Z; Xiong HC; Chen KN
PLoS One; 2015; 10(6):e0130551. PubMed ID: 26076456
[TBL] [Abstract][Full Text] [Related]
33. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7.
Hong Z; Fu W; Wang Q; Zeng Y; Qi L
Biomed Pharmacother; 2019 Jun; 114():108822. PubMed ID: 30951946
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
[TBL] [Abstract][Full Text] [Related]
37. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
[TBL] [Abstract][Full Text] [Related]
39. High expression of HOXB7 is an unfavorable prognostic factor for solid malignancies: A meta-analysis.
Zhou T; Feng Z; Yang F; Zhu W; Cao J; Hou X; Zhao Y; Chen D
Medicine (Baltimore); 2022 Jan; 101(3):e28564. PubMed ID: 35060516
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.
Guo Y; Qin X; Chai B; Jia J; Yi J; Wang K; Hou X
Int J Clin Exp Pathol; 2019; 12(7):2682-2690. PubMed ID: 31934098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
